Hein J. Bernelot Moens

Ziekenhuis Groep Twente — Netherlands

Medicine · Health Sciences

25h-index2.7kcitations121works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(59), Systemic Lupus Erythematosus Research(23), Chronic Lymphocytic Leukemia Research(16), Lymphoma Diagnosis and Treatment(11), Autoimmune and Inflammatory Disorders Research(10)

Publications121 total

Improving efficiency of a rheumatology outpatient clinic through classification of newly referred patients
Rheumatology Advances in Practice·2025Open Access
AB1520 THE PERSPECTIVE OF DUTCH HEALTH CARE PROFESSIONALS ON THE USE OF ARTIFICIAL INTELLIGENCE IN RHEUMATOLOGY
Annals of the Rheumatic Diseases·2024
Recurrence risk of venous thromboembolism associated with systemic lupus erythematosus: A retrospective cohort study
Research and Practice in Thrombosis and Haemostasis·2022· 7 citedOpen Access
Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients
Rheumatology Advances in Practice·2022· 7 citedOpen Access
Retro-odontoid pseudotumor of the upper cervical spine as incidental finding in 17 cases: Mid term follow-up
Joint Bone Spine·2021
THU0304 CLINICAL PRACTICE VARIATION BETWEEN ACADEMIC AND NON-ACADEMIC CENTERS IN THE MANAGEMENT OF ANCA ASSOCIATED VASCULITIS IN THE NETHERLANDS
Annals of the Rheumatic Diseases·2020
A Dutch consensus statement on the diagnosis and treatment of ANCA-associated vasculitis.
PubMed·2020· 2 citedOpen Access
Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis (REDO study): a randomised controlled non-inferiority trial
The Lancet Rheumatology·2019· 32 cited
How do patients with systemic sclerosis experience currently provided healthcare and how should we measure its quality?
Lara D. Veeken·2019· 22 citedOpen Access
Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment
BMC Rheumatology·2019· 9 citedOpen Access
LB0010 ULTRA-LOW DOSES OF RITUXIMAB OR RETREATMENT OF RHEUMATOID ARTHRITIS: A RANDOMISED CONTROLLED NON-INFERIORITY TRIAL
Annals of the Rheumatic Diseases·2019· 1 citedOpen Access
Behandeling met methotrexaat: Vergelijking van dermatologische en reumatologische richtlijnen
Nederlands tijdschrift voor dermatologie en venereologie/Nederlands tijdschrift voor dermatologie & venereologie·2019
The Development and Evaluation of Personalized Training in Shared Decision-making Skills for Rheumatologists
The Journal of Rheumatology·2019· 5 citedOpen Access
Vergelijking van dermatologische en reumatologische richtlijnen
Nederlands tijdschrift voor dermatologie en venereologie/Nederlands tijdschrift voor dermatologie & venereologie·2019
Optimal care for systemic sclerosis patients: recommendations from a patient-centered and multidisciplinary mixed-method study and working conference
Clinical Rheumatology·2018· 29 citedOpen Access
THU0128 Do biological dmards prevent long term articular damage by rheumatoid arthritis in routine clinical care?
Annals of the Rheumatic Diseases·2018Open Access
Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment
PLoS ONE·2018· 25 citedOpen Access
An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity
Arthritis & Rheumatology·2018· 21 citedOpen Access
Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines
PLoS ONE·2018· 20 citedOpen Access
Feasibility of photoacoustic/ultrasound imaging of synovitis in finger joints using a point-of-care system
Photoacoustics·2017· 84 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Mart A F J van de Laar(9), Harald E. Vonkeman(6), Piet L. C. M. van Riel(6), J. K. van der Korst(6), Peter M. ten Klooster(5), Tim Jansen(5), Maarten Boers(5), J.A. Kauffman(5), Erik Taal(4), Mart AFJ van de Laar(4), John T. Sharp(4), Jane Angwin(4), J. Duryea(4), M.A.F.J. van de Laar(3), Jaap Fransen(3), Wietske Kievit(3), Alfons A den Broeder(3), Henk Visser(3), Marjan Ghiti Moghadam(3), Willem F. Lems(3)